Literature DB >> 32424571

Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.

Katalin Gémes1, Mats Talbäck1, Karin Modig1, Anders Ahlbom1, Anita Berglund1, Maria Feychting1, Anthony A Matthews2.   

Abstract

The World Health Organization and European Centre for Disease Prevention and Control suggest that individuals over the age of 70 years or with underlying cardiovascular disease, cancer, chronic obstructive pulmonary disease, asthma, or diabetes are at increased risk of severe COVID-19. However, the prevalence of these prognostic factors is unknown in many countries. We aimed to describe the burden and prevalence of prognostic factors of severe COVID-19 at national and county level in Sweden. We calculated the burden and prevalence of prognostic factors for severe COVID-19 based on records from the Swedish national health care and population registers for 3 years before 1st January 2016. 9,624,428 individuals were included in the study population. 22.1% had at least one prognostic factor for severe COVID-19 (2,131,319 individuals), and 1.6% had at least three factors (154,746 individuals). The prevalence of underlying medical conditions ranged from 0.8% with chronic obstructive pulmonary disease (78,516 individuals) to 7.4% with cardiovascular disease (708,090 individuals), and the county specific prevalence of at least one prognostic factor ranged from 19.2% in Stockholm (416,988 individuals) to 25.9% in Kalmar (60,005 individuals). We show that one in five individuals in Sweden is at increased risk of severe COVID-19. When compared with the critical care capacity at a local and national level, these results can aid authorities in optimally planning healthcare resources during the current pandemic. Findings can also be applied to underlying assumptions of disease burden in modelling efforts to support COVID-19 planning.

Entities:  

Keywords:  Burden of disease; COVID-19; Prevalence; Prognostic factors

Mesh:

Year:  2020        PMID: 32424571      PMCID: PMC7233678          DOI: 10.1007/s10654-020-00646-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  21 in total

1.  Pattern of Cardiovascular Comorbidity in COPD in a Country with Low-smoking Prevalence: Results from Two-population-based Cohorts from Sweden.

Authors:  Berne Eriksson; Helena Backman; Linda Ekerljung; Malin Axelsson; Anne Lindberg; Eva Rönmark; Bo Lundbäck
Journal:  COPD       Date:  2018-11-26       Impact factor: 2.409

2.  Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys.

Authors:  Helena Backman; Petri Räisänen; Linnea Hedman; Caroline Stridsman; Martin Andersson; Anne Lindberg; Bo Lundbäck; Eva Rönmark
Journal:  Clin Exp Allergy       Date:  2017-07-12       Impact factor: 5.018

3.  The completeness of the Swedish Cancer Register: a sample survey for year 1998.

Authors:  Lotti Barlow; Kerstin Westergren; Lars Holmberg; Mats Talbäck
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

4.  Registers of the Swedish total population and their use in medical research.

Authors:  Jonas F Ludvigsson; Catarina Almqvist; Anna-Karin Edstedt Bonamy; Rickard Ljung; Karl Michaëlsson; Martin Neovius; Olof Stephansson; Weimin Ye
Journal:  Eur J Epidemiol       Date:  2016-01-14       Impact factor: 8.082

5.  Prevalence and incidence of diabetes in Stockholm County 1990-2010.

Authors:  Tomas Andersson; Anders Ahlbom; Cecilia Magnusson; Sofia Carlsson
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research.

Authors:  Jonas F Ludvigsson; Petra Otterblad-Olausson; Birgitta U Pettersson; Anders Ekbom
Journal:  Eur J Epidemiol       Date:  2009-06-06       Impact factor: 8.082

8.  Covid-19: risk factors for severe disease and death.

Authors:  Rachel E Jordan; Peymane Adab; K K Cheng
Journal:  BMJ       Date:  2020-03-26

9.  Diabetes Prevalence in Sweden at Present and Projections for Year 2050.

Authors:  Tomas Andersson; Anders Ahlbom; Sofia Carlsson
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action.

Authors:  Qianying Lin; Shi Zhao; Daozhou Gao; Yijun Lou; Shu Yang; Salihu S Musa; Maggie H Wang; Yongli Cai; Weiming Wang; Lin Yang; Daihai He
Journal:  Int J Infect Dis       Date:  2020-03-04       Impact factor: 3.623

View more
  13 in total

1.  Acceptance or Rejection of the COVID-19 Vaccine: A Study on Iranian People's Opinions toward the COVID-19 Vaccine.

Authors:  Amin Nakhostin-Ansari; Gregory D Zimet; Mohammad Saeid Khonji; Faezeh Aghajani; Azin Teymourzadeh; Amir Ali Rastegar Kazerooni; Pendar Pirayandeh; Reyhaneh Aghajani; Sepideh Safari; Kamand Khalaj; Amir Hossein Memari
Journal:  Vaccines (Basel)       Date:  2022-04-23

2.  Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?

Authors:  Emine Vezir; Mina Hizal; Burcu Cura Yayla; Kubra Aykac; Arzu Yilmaz; Gamze Kaya; Pembe Derin Oygar; Yasemin Ozsurekci; Mehmet Ceyhan
Journal:  Allergy Asthma Proc       Date:  2021-11-01       Impact factor: 2.587

3.  The effect of COVID-19 lockdown on lifestyle and mood in Croatian general population: a cross-sectional study.

Authors:  Zoran Đogaš; Linda Lušić Kalcina; Ivana Pavlinac Dodig; Sijana Demirović; Katarina Madirazza; Maja Valić; Renata Pecotić
Journal:  Croat Med J       Date:  2020-08-31       Impact factor: 1.351

4.  Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019.

Authors:  Burcin Beken; Gokcen Kartal Ozturk; Fatma Deniz Aygun; Cigdem Aydogmus; Himmet Haluk Akar
Journal:  Ann Allergy Asthma Immunol       Date:  2021-01-23       Impact factor: 6.347

5.  Years of life lost to COVID-19 in 81 countries.

Authors:  Héctor Pifarré I Arolas; Enrique Acosta; Guillem López-Casasnovas; Adeline Lo; Catia Nicodemo; Tim Riffe; Mikko Myrskylä
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

6.  Clinical and laboratory characteristics of severe and non-severe patients with COVID-19: A retrospective cohort study in China.

Authors:  Shaorui Shi; Bin Nie; Xinzu Chen; Qiang Cai; Chunxin Lin; Guangda Zhao; Xingying Zhang
Journal:  J Clin Lab Anal       Date:  2021-01-02       Impact factor: 2.352

7.  SARS-CoV-2 outbreak and lockdown in a Northern Italy hospital. Comparison with Scandinavian no-lockdown country.

Authors:  Federico Carbone; Fabrizio Montecucco
Journal:  Eur J Clin Invest       Date:  2020-06-07       Impact factor: 5.722

8.  Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome.

Authors:  Agnieszka Neumann-Podczaska; Michal Chojnicki; Lukasz M Karbowski; Salwan R Al-Saad; Abbas A Hashmi; Jerzy Chudek; Slawomir Tobis; Sylwia Kropinska; Iwona Mozer-Lisewska; Aleksandra Suwalska; Andrzej Tykarski; Katarzyna Wieczorowska-Tobis
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

9.  Asthma phenotypes, comorbidities, and disease activity in COVID-19: The need of risk stratification.

Authors:  Giulia Carli; Lorenzo Cecchi; Justin Stebbing; Paola Parronchi; Alessandro Farsi
Journal:  Allergy       Date:  2020-08-24       Impact factor: 14.710

10.  Burden and prevalence of risk factors for severe COVID-19 disease in the ageing European population - A SHARE-based analysis.

Authors:  Linda Juel Ahrenfeldt; Camilla Riis Nielsen; Sören Möller; Kaare Christensen; Rune Lindahl-Jacobsen
Journal:  Res Sq       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.